AVADEL PHARMACEUTICALS PLC - AVDL
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$162.5M
QoQ value delta ($000)
-$1.58B
(-90.68%)
Implied price effect (QoQ)
+0.02%
Shares
Total shares
7,539,445
QoQ shares delta
-73,352,088
(-90.68%)
Total shares held by funds (by quarter)
Market chart (AVDL)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD GROUP INC | 126,386 | 5,864,781 | 0.0% |
| KOTLER KEVIN | 34,927 | 1,620,743 | 8.17% |
| TWO SIGMA ADVISERS, LP | 989 | 45,900 | 0.0% |
| CIBC Private Wealth Group LLC | 172 | 8,000 | 0.0% |
| HUNTINGTON NATIONAL BANK | 0 | 1 | 0.0% |
| IFP Advisors, Inc | 0 | 20 | 0.0% |